Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Given Average Recommendation of “Moderate Buy” by Brokerages
MarketBeatCollegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has earned an average rating of “Moderate Buy” from the five analysts that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold r…